display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced - colorectal cancer (mCRC)
mCRC - 1st line (L1)mCRC - 2nd line (L2)
chemotherapy
non platinum-based chemotherapy
nucleoside analogues (pyrimidine/purine)
capecitabine BACCI BACCI
Standard of Care (SoC) Columbia 1

Study type: